Previous 10 | Next 10 |
2024-02-29 21:00:14 ET Image source: The Motley Fool. Organogenesis (NASDAQ: ORGO) Q4 2023 Earnings Call Feb 29, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis (ORGO) Q4 2023 Earnings Call Transcript
CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today re...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...
2024-02-08 19:05:53 ET More on Organogenesis Holdings Seeking Alpha’s Quant Rating on Organogenesis Holdings Historical earnings data for Organogenesis Holdings Financial information for Organogenesis Holdings Read the full article on Seeking Alpha ...
CANTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...
2023-11-10 10:00:06 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employ...
2023-11-10 08:17:54 ET Motus GI Holdings ( MOTS ) +64% Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu EVS Gastro. Direct Digital Holdings ( DRCT ) +44% Digital Holdings, Inc. (DRCT) - FORM 10-Q | Quarterly Report. AVITA Medical ( RCEL ...
2023-11-09 22:16:02 ET Organogenesis Holdings, Inc. (ORGO) Q3 2023 Earnings Conference Call November 09, 2023, 05:00 PM EST Company Participants Gary Gillheeney - President, CEO & Chair David Francisco - CFO Conference Call Participants Ryan Zimmerman...
2023-11-09 19:45:14 ET Image source: The Motley Fool. Organogenesis (NASDAQ: ORGO) Q3 2023 Earnings Call Nov 09, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis (ORGO) Q3 2023 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...